PMID- 29997937 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230926 IS - 2072-1439 (Print) IS - 2077-6624 (Electronic) IS - 2072-1439 (Linking) VI - 10 IP - 5 DP - 2018 May TI - Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species. PG - 2752-2759 LID - 10.21037/jtd.2018.04.112 [doi] AB - BACKGROUND: Cachexia, a wasting syndrome, is most commonly observed in individuals with advanced cancer including lung cancer, esophageal cancer, liver cancer, etc. The characteristic sign of cachexia is muscle atrophy. To date, effective countermeasures have been still deficiency to alleviate muscle atrophy. Reactive oxygen species (ROS) are important regulators of muscle atrophy. Therefore, the effects of a naturally antioxidant, pyrroloquinoline quinone (PQQ), were explored on muscle atrophy induced by cachexia in the present study. METHODS: Tumor necrosis factor-alpha (TNF-alpha) induced C2C12 myotubes atrophy model was constructed. The atrophied C2C12 myotubes were dealt with the presence or absence of N-acetyl-L-cysteine (NAC, an antioxidant for ROS abolition) (5 mM) or PQQ (80 microM) for 24 hours. ROS content was determined by dichlorodihydrofluorescein diacetate (DCFH-DA) staining. The diameter of myotubes was analyzed by myosin heavy chain (MHC) staining. The protein levels of MHC, muscle atrophy F-box (MAFbx) and muscle RING finger-1 (MuRF-1) in each group were observed by Western blotting. RESULTS: First, ROS generation was enhanced in C2C12 myotubes treated with TNF-alpha. NAC treatments significantly avoided the reduction in the diameter of C2C12 myotubes, and concomitantly increased MHC levels, and decreased ROS contents, MuRF1 and MAFbx levels. These data suggested that the increased ROS induced by TNF-alpha might play a central role in muscle wasting. PQQ (a naturally occurring antioxidant) administration inhibited C2C12 myotubes atrophy induced by TNF-alpha, as evidenced by the increase of the diameter of C2C12 myotubes, together with increased MHC levels and decreased ROS, MAFbx and MuRF-1 levels. CONCLUSIONS: PQQ resists atrophic effect dependent on, at least in part, decreased ROS in skeletal muscle treated with TNF-alpha. FAU - Xu, Tongtong AU - Xu T AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. AD - School of Medicine, Nantong University, Nantong 226001, China. FAU - Yang, Xiaoming AU - Yang X AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. FAU - Wu, Changyue AU - Wu C AD - School of Medicine, Nantong University, Nantong 226001, China. FAU - Qiu, Jiaying AU - Qiu J AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. FAU - Fang, Qingqing AU - Fang Q AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. FAU - Wang, Lingbin AU - Wang L AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. FAU - Yu, Shu AU - Yu S AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. FAU - Sun, Hualin AU - Sun H AD - Laboratory of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China. LA - eng PT - Journal Article PL - China TA - J Thorac Dis JT - Journal of thoracic disease JID - 101533916 PMC - PMC6006103 OTO - NOTNLM OT - Pyrroloquinoline quinone (PQQ) OT - muscle atrophy OT - oxidative stress COIS- Conflicts of Interest: The authors have no conflicts of interest to declare. EDAT- 2018/07/13 06:00 MHDA- 2018/07/13 06:01 PMCR- 2018/05/01 CRDT- 2018/07/13 06:00 PHST- 2018/07/13 06:00 [entrez] PHST- 2018/07/13 06:00 [pubmed] PHST- 2018/07/13 06:01 [medline] PHST- 2018/05/01 00:00 [pmc-release] AID - jtd-10-05-2752 [pii] AID - 10.21037/jtd.2018.04.112 [doi] PST - ppublish SO - J Thorac Dis. 2018 May;10(5):2752-2759. doi: 10.21037/jtd.2018.04.112.